Cholangiocarcinoma miscoding in hepatobiliary centres
Shaun Selvadurai(Barts Health NHS Trust), Shahid Ali Khan(City University of Hong Kong), Kulbir Mann(University of Liverpool), Sanjina Mithra, John Bridgewater(University College London Hospitals NHS Foundation Trust), Hassan Malik(University of Liverpool)
Cited by 4
Related Papers
Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer
|New England Journal of Medicine|2010|4.5k
Cholangiocarcinoma 2020: the next horizon in mechanisms and management
|Nature Reviews Gastroenterology & Hepatology|2020|2.5k
Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study
|The Lancet Oncology|2019|1.2k